The Ohio State University | Strategic Alliance Partners

Latest from The Ohio State University

Dr. Rogers on the Next Steps With Obinutuzumab/Ibrutinib/Venetoclax in CLL

April 12, 2021

Video

Kerry A. Rogers, MD, discusses the next steps with the triplet combination of obinutuzumab, ibrutinib, and venetoclax in chronic lymphocytic leukemia.

Pushing Toward Time-Limited Options and More Tolerable PI3K Inhibitors in CLL

March 12, 2021

Article

Seema A. Bhat, MD, discusses updates from key studies and highlighted the promise of novel PI3K inhibitors in chronic lymphocytic leukemia.

Epperla Elucidates on Excitement With Tafasitamab and Selinexor in DLBCL

February 15, 2021

Article

Narendranath Epperla, MD, MS, expands on findings from the L-MIND trial in DLBCL, as well as the significance of selinexor and other options in the pipeline.

Expert Gives Nod to COVID-19 Vaccines for Patients With Cancer

January 22, 2021

Article

David Cohn, MD, discusses how to approach COVID-19 vaccination in patients with cancer.

Leukemia/Lymphoma: Chaired by Narendranath Epperla, MD, MS

December 16, 2020

Video

Early detection, personalized treatment approaches, and increased situational awareness have improved cancer patient survival rates. Ongoing dialogue among leading experts can only improve patient outcomes and advance the field of leukemias and lymphomas.

Dr. Pawlik on Advances in Management of mCRC With Liver Metastases

December 09, 2020

Video

Timothy M. Pawlik, MD, PhD, MPH, discusses advances in the management of patients with metastatic colorectal cancer with liver metastases.